Previous close | 0.0500 |
Open | 0.0500 |
Bid | 0.0000 |
Ask | 0.1000 |
Strike | 130.00 |
Expiry date | 2024-05-17 |
Day's range | 0.0500 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 104 |
Director John Kurtzweil of Axcelis Technologies Inc (NASDAQ:ACLS) sold 1,200 shares of the company on May 20, 2024.
Based on the average brokerage recommendation (ABR), Axcelis (ACLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: